Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early response to abatacept plus methotrexate assessed by power Doppler ultrasonography in active rheumatoid arthritis
2008-001523-57Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Sep 2008
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of abatacept in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Primary endpoint: Early response assessed by power Doppler ultrasonography. Started Sep 2008; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2008-001523-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001523-57.